Strasser, S;
Abou-Alfa, G;
Mollon, P;
Meyer, T;
Cheng, A;
El-Khoueiry, A;
Kelley, R;
... Freemantle, N; + view all
(2019)
Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial.
Presented at: Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, Australia.
Preview |
Text
Freemantle_Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial_AAM.pdf - Accepted Version Download (253kB) | Preview |
Archive Staff Only
View Item |